HK1037531A1 - Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method - Google Patents

Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method

Info

Publication number
HK1037531A1
HK1037531A1 HK01108330A HK01108330A HK1037531A1 HK 1037531 A1 HK1037531 A1 HK 1037531A1 HK 01108330 A HK01108330 A HK 01108330A HK 01108330 A HK01108330 A HK 01108330A HK 1037531 A1 HK1037531 A1 HK 1037531A1
Authority
HK
Hong Kong
Prior art keywords
antifungic
compound
preparation
coat
acitivity
Prior art date
Application number
HK01108330A
Other languages
English (en)
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa Liberacion Controlada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1037531(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberacion Controlada filed Critical Liconsa Liberacion Controlada
Publication of HK1037531A1 publication Critical patent/HK1037531A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
HK01108330A 1998-07-21 2001-11-27 Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method HK1037531A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
HK1037531A1 true HK1037531A1 (en) 2002-02-15

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108330A HK1037531A1 (en) 1998-07-21 2001-11-27 Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method

Country Status (31)

Country Link
US (1) US6737082B1 (sh)
EP (1) EP1103252B1 (sh)
JP (1) JP4190732B2 (sh)
KR (1) KR100572135B1 (sh)
AT (1) ATE234077T1 (sh)
AU (1) AU750730B2 (sh)
BG (1) BG65187B1 (sh)
BR (1) BR9912300A (sh)
CA (1) CA2337509C (sh)
CZ (1) CZ291938B6 (sh)
DE (1) DE69905905T2 (sh)
DK (1) DK1103252T3 (sh)
EE (1) EE04415B1 (sh)
ES (2) ES2157731B1 (sh)
HK (1) HK1037531A1 (sh)
HR (1) HRP20010128B1 (sh)
HU (1) HU228895B1 (sh)
IL (1) IL140910A (sh)
ME (1) MEP26708A (sh)
MX (1) MXPA01000681A (sh)
NO (1) NO320054B1 (sh)
NZ (1) NZ509886A (sh)
PL (1) PL194740B1 (sh)
PT (1) PT1103252E (sh)
RS (1) RS50063B (sh)
RU (1) RU2209628C2 (sh)
SK (1) SK283279B6 (sh)
TR (1) TR200100177T2 (sh)
UA (1) UA64009C2 (sh)
WO (1) WO2000004881A1 (sh)
ZA (1) ZA200101293B (sh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE262799T1 (de) * 1996-01-31 2004-04-15 Univ South Alabama Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DE60312636T3 (de) * 2003-01-14 2014-12-24 Acino Pharma Ag Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
WO2005011702A1 (en) * 2003-07-17 2005-02-10 Tibotec Pharmaceuticals Ltd. Process for preparing particles containing an antiviral
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP2404602A1 (en) 2005-08-22 2012-01-11 The Johns Hopkins University Hedgehog pathway antagonists to treat cancer
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2542222A2 (de) * 2010-03-05 2013-01-09 Basf Se Schmelzüberzogene arzneiformen
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
RU2017141029A (ru) * 2015-05-25 2019-06-25 Сан Фармасьютикал Индастриз Лимитед Фармацевтическая пероральная композиция изотретиноина для применения один раз в сутки
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
NZ330739A (en) * 1996-05-20 1999-06-29 Janssen Pharmaceutica Nv Particulate solid dispersion of itraconazole and a water soluble polymer
CA2255663C (en) * 1996-05-24 2002-08-20 Schering Corporation Antifungal composition with enhanced bioavailability
CN1228693A (zh) * 1996-06-28 1999-09-15 先灵公司 含有三唑类抗真菌化合物的口服组合物
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
ATE241969T1 (de) * 1997-03-26 2003-06-15 Janssen Pharmaceutica Nv Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist

Also Published As

Publication number Publication date
ZA200101293B (en) 2001-08-21
KR20010070990A (ko) 2001-07-28
CA2337509A1 (en) 2000-02-03
RS50063B (sr) 2009-01-22
NO320054B1 (no) 2005-10-17
YU3901A (sh) 2003-08-29
PL194740B1 (pl) 2007-06-29
CZ2001175A3 (en) 2001-05-16
ES2157731B1 (es) 2002-05-01
HUP0103708A3 (en) 2002-07-29
ES2157731A1 (es) 2001-08-16
IL140910A (en) 2004-03-28
MEP26708A (en) 2010-06-10
DE69905905T2 (de) 2004-03-04
NO20010289D0 (no) 2001-01-17
IL140910A0 (en) 2002-02-10
DE69905905D1 (de) 2003-04-17
US6737082B1 (en) 2004-05-18
HRP20010128A2 (en) 2002-12-31
BG65187B1 (bg) 2007-06-29
RU2209628C2 (ru) 2003-08-10
DK1103252T3 (da) 2003-07-14
KR100572135B1 (ko) 2006-04-19
BG105282A (en) 2001-11-30
CZ291938B6 (cs) 2003-06-18
NZ509886A (en) 2002-09-27
ATE234077T1 (de) 2003-03-15
AU750730B2 (en) 2002-07-25
BR9912300A (pt) 2001-04-17
UA64009C2 (en) 2004-02-16
JP2002521323A (ja) 2002-07-16
HRP20010128B1 (en) 2003-12-31
TR200100177T2 (tr) 2001-07-23
HU228895B1 (en) 2013-06-28
AU4782199A (en) 2000-02-14
ES2194480T3 (es) 2003-11-16
EE200100041A (et) 2002-06-17
JP4190732B2 (ja) 2008-12-03
SK283279B6 (sk) 2003-05-02
HUP0103708A2 (hu) 2002-02-28
SK862001A3 (en) 2001-08-06
CA2337509C (en) 2005-12-27
EE04415B1 (et) 2005-02-15
EP1103252B1 (en) 2003-03-12
NO20010289L (no) 2001-03-07
EP1103252A1 (en) 2001-05-30
WO2000004881A1 (es) 2000-02-03
PT1103252E (pt) 2003-07-31
PL345625A1 (en) 2002-01-02
MXPA01000681A (es) 2002-04-24

Similar Documents

Publication Publication Date Title
HK1037531A1 (en) Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method
DE69431807T2 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
CA2322875A1 (en) A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in solid form
HUT50050A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions
AU3100700A (en) Antibiotic hydrophilic polymer coating
CA2348398A1 (en) Water-soluble coating agents bearing initiator groups and coating process
CA2281420A1 (en) Preparation of pharmaceutically-active granules
EP0351760A3 (en) Feed additive for ruminants
DE69100670D1 (de) Eine Suspension hydratisierter Spheroide einer hydrophilen Lipidsubstanz enthaltendes wässriges kosmetisches bzw. dermopharmazeutisches Mittel.
HK1063017A1 (en) Microgranules based on active principle and methodfor making same
AU1470195A (en) Nanoparticles containing an active substance and a ketalizedpolytartramidic acid, process for their preparation, and use thereof
EP0998944A3 (en) Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
KR987000980A (en) Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090720